The importance of PD-1 and other inhibitory receptors in mitigating T cell function and prolonging longevity are well-established in animal models and humans, where blockade of PD-1 or PD-L1 reinvigorates T cell responses, reduces viral load, and/or boosts tumor control. Here, PDCD1 is linked to neoplasm.